Unknown NA INTERVENTIONAL NCT00197470

Cytokine Gene Polymorphisms in Gastric Diseases

Effects of Pro-Inflammatory and Anti-Inflammatory Cytokine Gene Polymorphism on the Development of Gastric Cancer and Peptic Ulcer in Japanese

Sponsor: Hamamatsu University

Conditions Duodenal Ulcer Gastric Cancer Gastric Ulcer

Interventions IL-1, TNF-alpha, Il-10

Updated 4 times since 2017 Last updated: Sep 12, 2005 Started: Jan 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Duodenal Ulcer and Gastric Cancer, this trial is ongoing. The trial is conducted by Hamamatsu University and has accumulated 4 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamamatsu University
Yokoyama Foundation for Clinical Pharmacology

Data source: Hamamatsu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamamatsu, Japan